Literature DB >> 11478846

Replication timing of amplified genetic regions relates to intranuclear localization but not to genetic activity or G/R band.

N Shimizu1, T Ochi, K Itonaga.   

Abstract

Amplified genes in many human cancer cells usually localize at the extrachromosomal double minutes (DMs). In the present study, we show that multiple DMs in the human colorectal tumor COLO 320DM line replicated semisynchronously during the early S phase. On the other hand, during longer passage of the cells with DMs, cells with the amplified genes at the chromosomal homogeneously staining region (HSR) generally dominate the population. We currently report that HSR was composed of a tandem array of DM-derived sequences, which was shown using a unique DM-painting probe. Nevertheless, we found that HSR was replicated much later during the S phase, unless the amplified c-myc genes were expressed almost equally from DMs and HSR. Therefore, this provided a novel instance in which the cytogenetic localization affected replication timing without alteration of expression. Furthermore, we unexpectedly found that HSR had a distinctive band structure with respect to replication timing. The replication band structure was usually associated with the chromosomal G/R bands; however, HSR was homogeneous in the G/R band and in the distribution of highly repetitive sequences. We discuss the mechanism by which the replication band may arise, in relation to the folding of chromatin inside the nucleus. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478846     DOI: 10.1006/excr.2001.5286

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

Review 1.  Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.

Authors:  Imran Noorani; Paul S Mischel; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2022-09-21       Impact factor: 65.011

Review 2.  The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy.

Authors:  Eric van Leen; Lotte Brückner; Anton G Henssen
Journal:  Nat Genet       Date:  2022-02-10       Impact factor: 41.307

3.  How transcription proceeds in a large artificial heterochromatin in human cells.

Authors:  Koh-ichi Utani; Noriaki Shimizu
Journal:  Nucleic Acids Res       Date:  2008-11-29       Impact factor: 16.971

4.  Episomal high copy number maintenance of hairpin-capped DNA bearing a replication initiation region in human cells.

Authors:  Seiyu Harada; Masafumi Uchida; Noriaki Shimizu
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

Review 5.  The contributions of extrachromosomal DNA elements in neoplasm progression.

Authors:  Jiawei Hong; Shusen Zheng; Donghai Jiang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

6.  Amplification of a plasmid bearing a mammalian replication initiation region in chromosomal and extrachromosomal contexts.

Authors:  Seiyu Harada; Naoki Sekiguchi; Noriaki Shimizu
Journal:  Nucleic Acids Res       Date:  2010-10-06       Impact factor: 16.971

7.  Generation of micronuclei during interphase by coupling between cytoplasmic membrane blebbing and nuclear budding.

Authors:  Koh-ichi Utani; Atsushi Okamoto; Noriaki Shimizu
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

8.  Dissection of the beta-globin replication-initiation region reveals specific requirements for replicator elements during gene amplification.

Authors:  Naoya Okada; Noriaki Shimizu
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

Review 9.  Extrachromosomal circular DNA: a new potential role in cancer progression.

Authors:  Tianyi Wang; Haijian Zhang; Youlang Zhou; Jiahai Shi
Journal:  J Transl Med       Date:  2021-06-10       Impact factor: 5.531

10.  Epigenetic Repeat-Induced Gene Silencing in the Chromosomal and Extrachromosomal Contexts in Human Cells.

Authors:  Sho-Hei Mitsuda; Noriaki Shimizu
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.